Synthesis and in vivo pharmacokinetic evaluation of degradable shell cross-linked polymer nanoparticles with poly(carboxybetaine) versus poly(ethylene glycol) surface-grafted coatings.

Nanoparticles with tunable pharmacokinetics are desirable for various biomedical applications. Poly(ethylene glycol) (PEG) is well-known to create "stealth" effects to stabilize and extend the blood circulation of nanoparticles. In this work, poly(carboxybetaine) (PCB), a new nonfouling polymer material, was incorporated as surface-grafted coatings, conjugated onto degradable shell cross-linked knedel-like nanoparticles (dSCKs) composed of poly(acrylic acid)-based shells and poly(lactic acid) cores, to compare the in vivo pharmacokinetics to their PEG-functionalized analogues. A series of five dSCKs was prepared from amphiphilic block copolymers, having different numbers and lengths of either PEG or PCB grafts, by supramolecular assembly in water followed by shell cross-linking, and then studied by a lactate assay to confirm their core hydrolytic degradabilities. Each dSCK was also conjugated with 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid macrocyclic chelators and tyramine moieties to provide for (64)Cu and/or radiohalogen labeling. The high specific activity of (64)Cu radiolabeling ensured nanogram administration of dSCKs for in vivo evaluation of their pharmacokinetics. Biodistribution studies demonstrated comparable in vivo pharmacokinetic profiles of PCB-grafted dSCKs to their PEG-conjugated counterparts. These results indicated that PCB-functionalized dSCKs have great potential as a theranostic platform for translational research.

[1]  Vladimir P Torchilin,et al.  PEG-based micelles as carriers of contrast agents for different imaging modalities. , 2002, Advanced drug delivery reviews.

[2]  Monica Shokeen,et al.  Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis , 2009, Proceedings of the National Academy of Sciences.

[3]  D. Wilbur,et al.  Radiohalogens for imaging and therapy. , 2005, Chemical Society reviews.

[4]  Paula T Hammond,et al.  The effects of polymeric nanostructure shape on drug delivery. , 2011, Advanced drug delivery reviews.

[5]  Lev Dykman,et al.  Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. , 2011, Chemical Society reviews.

[6]  Robert M. Waymouth,et al.  Guanidine and Amidine Organocatalysts for Ring-Opening Polymerization of Cyclic Esters , 2006 .

[7]  Meredith A Mintzer,et al.  Nonviral vectors for gene delivery. , 2009, Chemical reviews.

[8]  Robert Langer,et al.  Nanoparticle delivery of cancer drugs. , 2012, Annual review of medicine.

[9]  M. Hershfield,et al.  Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase , 2005, Arthritis research & therapy.

[10]  M J Welch,et al.  Efficient production of high specific activity 64Cu using a biomedical cyclotron. , 1997, Nuclear medicine and biology.

[11]  J C Middleton,et al.  Synthetic biodegradable polymers as orthopedic devices. , 2000, Biomaterials.

[12]  Herbert J Meiselman,et al.  Antibody against poly(ethylene glycol) adversely affects PEG‐asparaginase therapy in acute lymphoblastic leukemia patients , 2007, Cancer.

[13]  Shaoyi Jiang,et al.  Protein interactions with oligo(ethylene glycol) (OEG) self-assembled monolayers: OEG stability, surface packing density and protein adsorption , 2007, Journal of biomaterials science. Polymer edition.

[14]  T. Kondo,et al.  Preparation and in vitro degradation properties of polylactide microcapsules. , 1985, Chemical & pharmaceutical bulletin.

[15]  Hatem Fessi,et al.  In vitro degradation of nanospheres from poly(D,L-lactides) of different molecular weights and polydispersities , 1996 .

[16]  C. Gorman,et al.  Effects of Temperature and pH on the Degradation of Poly(lactic acid) Brushes , 2011 .

[17]  Vladimir P Torchilin,et al.  Multifunctional nanocarriers. , 2006, Advanced drug delivery reviews.

[18]  Leaf Huang,et al.  Pharmacokinetics and biodistribution of nanoparticles. , 2008, Molecular pharmaceutics.

[19]  Xiabin Jing,et al.  Biodegradable synthetic polymers: Preparation, functionalization and biomedical application , 2012 .

[20]  J. Homola,et al.  Ultralow fouling and functionalizable surface chemistry based on a zwitterionic polymer enabling sensitive and specific protein detection in undiluted blood plasma. , 2008, Analytical chemistry.

[21]  Shaoyi Jiang,et al.  Uniform zwitterionic polymer hydrogels with a nonfouling and functionalizable crosslinker using photopolymerization. , 2011, Biomaterials.

[22]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[23]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[24]  Zhi-xin Xu,et al.  Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C. , 2001, Bioconjugate chemistry.

[25]  K. Wooley,et al.  Orthogonally dual-clickable Janus nanoparticles via a cyclic templating strategy. , 2011, Journal of the American Chemical Society.

[26]  Andreas M. Nyström,et al.  Tuning core vs. shell dimensions to adjust the performance of nanoscopic containers for the loading and release of doxorubicin. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[27]  F. Veronese,et al.  The Impact of PEGylation on Biological Therapies , 2012, BioDrugs.

[28]  Eun Ji Shin,et al.  Organocatalysis: Opportunities and Challenges for Polymer Synthesis , 2010 .

[29]  Andreas M. Nyström,et al.  Facile, efficient approach to accomplish tunable chemistries and variable biodistributions for shell cross-linked nanoparticles. , 2008, Biomacromolecules.

[30]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[31]  Anderson,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.

[32]  Karen L. Wooley,et al.  Shell Cross-Linked Knedels: A Synthetic Study of the Factors Affecting the Dimensions and Properties of Amphiphilic Core-Shell Nanospheres , 1997 .

[33]  Lei Zhang,et al.  Functionalizable and ultra stable nanoparticles coated with zwitterionic poly(carboxybetaine) in undiluted blood serum. , 2009, Biomaterials.

[34]  K. Wooley,et al.  Strategies Toward Well-Defined Polymer Nanoparticles Inspired by Nature: Chemistry versus Versatility. , 2012, Journal of polymer science. Part A, Polymer chemistry.

[35]  Karen L. Wooley,et al.  The Importance of Chemistry in Creating Well-Defined Nanoscopic Embedded Therapeutics: Devices Capable of the Dual Functions of Imaging and Therapy , 2011, Accounts of chemical research.

[36]  L. Unsworth,et al.  Poly(carboxybetaine methacrylamide)-modified nanoparticles: a model system for studying the effect of chain chemistry on film properties, adsorbed protein conformation, and clot formation kinetics. , 2011, Biomacromolecules.

[37]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[38]  V. Gaberc-Porekar,et al.  Obstacles and pitfalls in the PEGylation of therapeutic proteins. , 2008, Current opinion in drug discovery & development.

[39]  D. Hume,et al.  The mononuclear phagocyte system. , 2006, Current opinion in immunology.

[40]  Craig J. Hawker,et al.  Strategies for Optimized Radiolabeling of Nanoparticles for in vivo PET Imaging , 2007 .

[41]  Buddy D. Ratner,et al.  PEO-like plasma polymerized tetraglyme surface interactions with leukocytes and proteins: in vitro and in vivo studies , 2002, Journal of biomaterials science. Polymer edition.

[42]  G. Whitesides,et al.  A Survey of Structure−Property Relationships of Surfaces that Resist the Adsorption of Protein , 2001 .

[43]  K. Rahbar,et al.  Multimodality molecular imaging — from target description to clinical studies , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[44]  A. P. Chapman,et al.  PEGylated antibodies and antibody fragments for improved therapy: a review. , 2002, Advanced drug delivery reviews.

[45]  Shaoyi Jiang,et al.  Dual-functional biomimetic materials: nonfouling poly(carboxybetaine) with active functional groups for protein immobilization. , 2006, Biomacromolecules.

[46]  Michael J Welch,et al.  Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications. , 2012, Bioconjugate chemistry.

[47]  Christine Vauthier,et al.  Pegylated Nanoparticles from a Novel Methoxypolyethylene Glycol Cyanoacrylate-Hexadecyl Cyanoacrylate Amphiphilic Copolymer , 1998, Pharmaceutical Research.

[48]  Shaoyi Jiang,et al.  Nanoparticles for drug delivery prepared from amphiphilic PLGA zwitterionic block copolymers with sharp contrast in polarity between two blocks. , 2010, Angewandte Chemie.

[49]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[50]  Shaoyi Jiang,et al.  Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity. , 2011, Nature chemistry.

[51]  Francesco M Veronese,et al.  PEGylation, successful approach to drug delivery. , 2005, Drug discovery today.

[52]  Jean-Pierre Benoit,et al.  Parameters influencing the stealthiness of colloidal drug delivery systems. , 2006, Biomaterials.

[53]  Joel A. Cohen,et al.  Impact of hydrogel nanoparticle size and functionalization on in vivo behavior for lung imaging and therapeutics. , 2009, Molecular pharmaceutics.

[54]  J. Jung,et al.  Acid- and base-catalyzed hydrolyses of aliphatic polycarbonates and polyesters , 2006 .

[55]  Karen L Wooley,et al.  Design of polymeric nanoparticles for biomedical delivery applications. , 2012, Chemical Society reviews.

[56]  Shaoyi Jiang,et al.  Ultralow‐Fouling, Functionalizable, and Hydrolyzable Zwitterionic Materials and Their Derivatives for Biological Applications , 2010, Advanced materials.

[57]  Yali Li,et al.  Degradability of poly(lactic acid)-containing nanoparticles: enzymatic access through a cross-linked shell barrier. , 2012, Journal of the American Chemical Society.